Turn Therapeutics, Inc. (TTRX)
12.00
+0.61
(+5.36%)
USD |
NASDAQ |
Oct 09, 16:00
11.95
-0.05
(-0.42%)
After-Hours: 20:00
Turn Therapeutics Shareholders Equity (Quarterly) : 0.6869M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.6869M |
| March 31, 2026 | 6.118M |
| December 31, 2025 | 5.757M |
| Date | Value |
|---|---|
| September 30, 2025 | 0.5567M |
| June 30, 2025 | 2.422M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| ANI Pharmaceuticals, Inc. | 597.21M |
| Corcept Therapeutics, Inc. | 705.78M |
| Veru, Inc. | 28.38M |
| Johnson & Johnson | 84.97B |
| Eli Lilly & Co. | 33.88B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 16.96M |
| Total Liabilities (Quarterly) | 16.27M |
| Debt to Equity Ratio | 8.911 |
| Current Ratio | 1.190 |
| Net Debt Paydown Yield | -0.56% |